Compare Bupivacaine vs Bupivacaine and Dexmedetomidine given in joint for Postoperative pain in Arthroscopic Knee surgery patients

Comparison of intra-articular Bupivacaine vs Bupivacaine and Dexmedetomidine for Postoperative Analgesia in Arthroscopic Knee surgery patients - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094268

Enrollment

Registered

2025-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: BUPIVACAINE(O.5%) 14 ml + 1ml NS intraoperative at end of surgery: GIVEN INTRA ARTICULAR IN KNEE JOINTS Control Intervention1: BUPIVACAINE (0.5%) 1ML AND DEXMEDETOMIDINE (50MCG) 14ML in

Eligibility

Inclusion criteria

Inclusion criteria: ASA (American Society of Anaesthesiologists) physical status I and II Age:18-60 years Patients scheduled for elective arthroscopic knee surgeries under spinal anesthesia Duration of surgery between 90-150 minutes

Exclusion criteria

Exclusion criteria: patients allergic to this drug, coagulation disorders , pregnant females , sepsis present , obesity

Design outcomes

Primary

Measure	Time frame
compare post op painTimepoint: compare post op pain FOR 24 HOURS	—

Secondary

Measure	Time frame
haemodynamics changessTimepoint: post op FOR 24 HOURS	—

Countries

India

Contacts

Public ContactDr Inderjeet Singh

Adesh Institute of Medical Sciences and Research

sonaattri45@gmail.com9915461044

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026